Fifteen more states reached an agreement with Purdue Pharma LP and members of its wealthy Sackler family owners that moved the OxyContin maker a step closer to resolving widespread opioid litigation and exiting bankruptcy protection.
Biogen Inc. agreed to pay $22 million to resolve U.S. allegations that the company illegally used two charities that help cover Medicare patients’ out-of-pocket drug costs as a means to pay them kickbacks to use the Cambridge, Mass-based drugmaker’s multiple sclerosis medicines.
Advanced Care Scripts Inc. will pay $3.5 million to resolve allegations that the Florida-based specialty pharmacy served as a conduit for a Teva Pharmaceutical Industries Ltd. subsidiary to pay kickbacks to Medicare patients, the U.S. Justice Department said.
London, UK-based Wellcome Trust, a research-charity, is working to raise $8 billion to battle COVID-19. The initiative is called the COVID-Zero, and the goal is to raise the funds by the end of April.
The Assistance Fund will pay $4 million to resolve claims that the Florida-based charity acted as a conduit for companies including Biogen Inc. and Novartis AG to pay kickbacks to Medicare patients using their high-priced multiple sclerosis drugs, the U.S. Justice Department said.
Two charities that provide patients with assistance in acquiring their medications will pay the federal government $6 million to resolve allegations the organizations acted as pass-through agencies for multiple pharmaceutical companies.
Seven Scoops ice cream shop in Pine Brook, New Jersey, is donating every penny of ice cream sales on Aug. 26th to support ALS Ice Bucket Challenge Co-Founder Pat Quinn.
Astellas and Amgen will pay nearly $125 million to resolve claims they used charities that help cover Medicare patients’ out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of their high-priced medications.
Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients’ out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of their medications.
A unit of Johnson & Johnson will pay $360 million to resolve an investigation into the company’s financial support of a charity that helped Medicare patients cover out-of-pocket drug costs.